NewsBenzingaTrevi Therapeutics宣布其2b期CORAL试验结果被美国胸科医师学会CHEST 2026年年会接受为口头报告 Trevi Therapeutics宣布其2b期CORAL试验结果被美国胸科医师学会CHEST 2026年年会接受为口头报告 Benzinga 2026.10.13 11:33 (GMT+0) Open on Benzinga Other news If Apple Cuts iPhone Units in 2027, This Stock Could Be a Big Loser Trust company AnchorWatch Trust Company launches Bitcoin custody service Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
